Ulcerative colitis trials in Moldova

In Moldova 10 Also abroad 382

10 trials · From ClinicalTrials.gov, checked 10 November 2026. Ask the study team whether a trial fits you.

Phase 2Enrolling by invitation
Long-term Safety and Efficacy of Multiple Long-acting Antibodies Alone and in Combinations for IBD
Where
Chisinau
Age
18 years and over
People
645 worldwide
Run by
Spyre Therapeutics, Inc.
See details and how to joinNCT07652294 · EU 2025-524640-35-00
Phase 1/2Taking people
Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
Where
Chisinau
Age
18 years to 75 years
People
270 worldwide
Run by
Xencor, Inc.
See details and how to joinNCT06619990
Phase 2Taking people
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
Where
Chisinau
Age
18 years to 75 years
People
645 worldwide
Run by
Spyre Therapeutics, Inc.
See details and how to joinNCT07012395 · EU 2025-521242-26-00
Phase 3Taking people
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
Where
Chisinau
Age
16 years to 80 years
People
980 worldwide
Run by
Sanofi
See details and how to joinNCT07184996
Phase 2Taking people
Confirmatory Clinical Study in Active Ulcerative Colitis
Where
Chisinau
Age
16 years and over
People
204 worldwide
Run by
MRM Health NV
See details and how to joinNCT07296315 · EU 2025-524682-24-00
Phase 1/2Taking people
A Study of MB-001 in Moderately to Severely Active Ulcerative Colitis
Where
Chisinau
Age
18 years to 75 years
People
100 worldwide
Run by
Mage Biologics
See details and how to joinNCT07374471 · EU 2025-524719-35-00
Phase 3Taking people
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
Where
Chisinau
Age
16 years to 80 years
People
751 worldwide
Run by
Sanofi
See details and how to joinNCT07185009
Phase 1Not yet taking people in Moldova
A Trial of HRS-7085 Tablets in Patients With Moderate to Severe Active Ulcerative Colitis
Where
Chisinau
Age
18 years to 75 years
People
8
Run by
Jiangsu HengRui Medicine Co., Ltd.
See details and how to joinNCT07760831
Phase 2Taking people
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
Where
Chisinau
Age
18 years to 80 years
People
140 worldwide
Run by
Mirador Therapeutics, Inc.
See details and how to joinNCT07113522
Phase 2Taking people
Safety and Efficacy of OD-07656 and of Subsequent Vedolizumab Therapy in Moderately to Severely Active Ulcerative Colitis
Where
Chisinau
Age
18 years to 75 years
People
57 worldwide
Run by
Odyssey Therapeutics, Inc.
See details and how to joinNCT06850727